Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates April 11, 2022 Auto Bot News 0 Pfizer plans to acquire ReViral and its respiratory syncytial virus therapeutic candidates to strengthen Pfizer’s capabilities in infectious disease research.